pI: 4.8483 |
Length (AA): 1198 |
MW (Da): 134599 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
62 | 508 | 3cb6 (A) | 0 | 437 | 24.00 | 0 | 1 | 0.618822 | -0.27 |
68 | 508 | 5ce6 (A) | 22 | 455 | 32.00 | 0 | 1 | 0.738714 | -0.59 |
69 | 508 | 3biq (A) | 6 | 445 | 28.00 | 0 | 1 | 0.678879 | -0.5 |
123 | 521 | 3ig4 (A) | 49 | 416 | 18.00 | 0 | 1 | 0.318755 | 0.78 |
509 | 653 | 5cwp (A) | 45 | 189 | 13.00 | 0 | 0.01 | 0.360735 | -1.55 |
800 | 1085 | 4z2n (A) | 646 | 926 | 50.00 | 0 | 1 | 0.871031 | -1.24 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite. | Gregory Hehl AB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_128055)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G10710 | FACT complex subunit SPT16 |
Babesia bovis | BBOV_II002690 | transcriptional regulator, putative |
Brugia malayi | Bm1_25885 | metallopeptidase family M24 containing protein |
Candida albicans | CaO19.2884 | similar to S. cerevisiae SPT16 (YGL207W) RNA Pol II transcriptional elongation regulator involved in chromatin remodeling |
Candida albicans | CaO19.10402 | similar to S. cerevisiae SPT16 (YGL207W) RNA Pol II transcriptional elongation regulator involved in chromatin remodeling |
Caenorhabditis elegans | CELE_F55A3.3 | Protein F55A3.3 |
Cryptosporidium hominis | Chro.70222 | DUF140-related |
Cryptosporidium parvum | cgd7_1930 | CDC68 like aminopeptidase family chromatinic protein (possible inactive enzyme) |
Dictyostelium discoideum | DDB_G0282677 | FACT complex subunit SPT16 |
Drosophila melanogaster | Dmel_CG1828 | CG1828 gene product from transcript CG1828-RB |
Echinococcus granulosus | EgrG_001138800 | FACT complex subunit SPT16 |
Entamoeba histolytica | EHI_109860 | chromatin-specific transcription elongation factor, putative |
Echinococcus multilocularis | EmuJ_001138800 | FACT complex subunit SPT16 |
Giardia lamblia | GL50803_17430 | DRE4 protein |
Homo sapiens | ENSG00000092201 | suppressor of Ty 16 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.29.0030 | transcription factor-like protein |
Leishmania donovani | LdBPK_290020.1 | transcription factor-like protein |
Leishmania infantum | LinJ.29.0020 | transcription factor-like protein |
Leishmania major | LmjF.29.0020 | transcription factor-like protein |
Leishmania mexicana | LmxM.08_29.0020 | transcription factor-like protein |
Loa Loa (eye worm) | LOAG_04502 | metallopeptidase family M24 containing protein |
Mus musculus | ENSMUSG00000035726 | suppressor of Ty 16 |
Neospora caninum | NCLIV_005190 | transcription elongation factor FACT 140 kDa, putative |
Oryza sativa | 4352155 | Os12g0446500 |
Oryza sativa | 4335478 | Os04g0321600 |
Onchocerca volvulus | OVOC12128 | FACT complex subunit SPT16 homolog |
Plasmodium berghei | PBANKA_1232200 | FACT complex subunit SPT16 |
Plasmodium falciparum | PF3D7_0517400 | FACT complex subunit SPT16, putative |
Plasmodium knowlesi | PKNH_1015900 | FACT complex subunit SPT16, putative |
Plasmodium vivax | PVX_080380 | FACT complex subunit SPT16, putative |
Plasmodium yoelii | PY05380 | DUF140-related |
Saccharomyces cerevisiae | YGL207W | chromatin-remodeling protein SPT16 |
Schistosoma japonicum | Sjp_0104280 | FACT complex subunit spt16, putative |
Schistosoma japonicum | Sjp_0200860 | expressed protein |
Schistosoma mansoni | Smp_088280 | chromatin-specific transcription elongation factor 140 kDa subunit (M24 family) |
Schmidtea mediterranea | mk4.001387.02 | FACT complex subunit SPT16 |
Schmidtea mediterranea | mk4.001387.01 | Chromatin-specific transcription elongation factor 140 kDa subunit |
Schmidtea mediterranea | mk4.029008.00 | FACT complex subunit SPT16 |
Trypanosoma brucei gambiense | Tbg972.3.6320 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.3.5620 | Facilitates chromatin transcription complex subunit spt16 |
Trypanosoma congolense | TcIL3000_3_3560 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509761.10 | Metallopeptidase family M24/FACT complex subunit (SPT16/CDC68)/Histone chaperone Rttp106-like, putative |
Toxoplasma gondii | TGME49_221670 | transcriptional elongation factor FACT140 |
Theileria parva | TP04_0312 | hypothetical protein |
Theileria parva | TP04_0311 | transcriptional regulator, putative |
Trichomonas vaginalis | TVAG_212800 | Clan MG, familly M24, aminopeptidase P-like metallopeptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.5620 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.5620 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.5620 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.5620 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F55A3.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F55A3.3 | Caenorhabditis elegans | slow growth | wormbase |
YGL207W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1232200 | Plasmodium berghei | Essential | plasmo |
TGME49_221670 this record | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.